
A research team at the Josep Carreras Leukaemia Research Institute examines the effect of HIV infection in patients who are being treated for a Non-Hodgkin aggressive lymphoma
A research team at the Josep Carreras Leukaemia Research Institute (IJC) has studied the two groups of patients (ones HIV positive and the others HIV free) who received the same combined chemotherapy for B-cell aggressive lymphoma. The results of this study have just been published in the international magazine AIDS.